Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira. (Q46504750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

James M Stocks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Mark Brantly

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

David Pollock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alan Barker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Friedrich Kueppers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

James F Donohue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Robert Sandhaus

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

language of work or name

English

0 references

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

COPD: Journal of Chronic Obstructive Pulmonary Disease

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

17-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

alpha1-antitrypsin deficiency (first of two parts).

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

An alternative to the use of two-sided tests in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

Purity, activity, and virus safety of a pasteurized antithrombin concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500493220

10.1080/15412550500493220

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17175661%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference